Mounjaro®
Starting from £179.99/mo
Start journey Learn moreConstipation is one of the more common side effects of tirzepatide, and Laxido (macrogol) is a widely used, gentle osmotic laxative that many people already have at home. Whether the two can safely be used at the same time is a question our prescribers hear most weeks. The short answer is that there is no known pharmacokinetic interaction between macrogol and tirzepatide, but timing, hydration and the underlying cause of your constipation all matter. Mounjaro is a prescription-only medicine requiring clinical assessment, so any decision about adding a laxative to your routine is worth discussing with your prescriber or pharmacist, especially if symptoms are persistent.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
No significant interaction between Laxido (macrogol 3350 with electrolytes) and tirzepatide has been identified in clinical evidence. Macrogol is an osmotic agent that stays in the gut and is not absorbed into the bloodstream, so it does not alter tirzepatide's pharmacology or how it acts on GIP and GLP-1 receptors. That is broadly reassuring.
The nuance is this: tirzepatide slows gastric emptying, which means food and medicines linger in the stomach longer than usual. While macrogol itself is unlikely to be affected, any oral medicine taken at the same time as a large volume of Laxido solution could theoretically have its absorption altered. The Mounjaro patient information leaflet, available in full on the Electronic Medicines Compendium, covers this general gastric-emptying point and is worth reading alongside the Laxido leaflet. If you take other regular oral medicines, flag the timing question with your prescriber before starting macrogol routinely.
For most people using Laxido occasionally and not taking other time-sensitive oral medicines, the practical risk is small. Still, habit matters: space things sensibly, stay well hydrated, and treat any new or worsening gut symptom as a reason to call your prescriber rather than simply adding more laxatives.
Tirzepatide slows the rate at which the stomach empties its contents into the small intestine. That is one of the mechanisms behind its appetite-reducing effect, and it is also why the gut can become sluggish in some people. Transit slows, stool dries out, and constipation follows. The NHS medicines page for tirzepatide lists constipation among the common side effects, alongside nausea, diarrhoea and indigestion.
It tends to be most noticeable in the first few weeks after starting treatment or after moving to a higher dose, when the body is adjusting to a new level of gastric slowing. For many people it settles on its own within a couple of weeks. Staying well hydrated helps considerably, as does eating enough fibre and keeping active. A temporary, gentle osmotic laxative like Laxido can play a useful supporting role during that adjustment window.
If constipation is severe, if it arrives suddenly alongside abdominal pain, or if it does not improve after a couple of weeks, those are not symptoms to manage at home with over-the-counter remedies. Severe, persistent abdominal pain that radiates to the back is one of the warning signs of pancreatitis, a rare but serious side effect that the MHRA highlighted in a January 2026 Drug Safety Update for GLP-1 medicines. Urgent medical assessment is the right response to that symptom pattern, not a laxative.
Laxido is dissolved in water and drunk as a solution, typically one to three sachets a day for short-term constipation relief. Because macrogol pulls water into the bowel to soften stool, adequate fluid intake is doubly important when you are taking tirzepatide: dehydration from any cause can compound the GI side effects of the medicine and, in severe cases, put stress on the kidneys.
Practical pointers that follow from the clinical picture: take Laxido at a separate time from any other oral medicines you use regularly, drink the solution steadily rather than all at once, and keep your overall daily fluid intake up. The package insert gives specific preparation and dosing instructions for Laxido, and you should follow those rather than adjusting the dose yourself. If you are using it more than occasionally, your prescriber is the right person to know about it.
For those managing weight with tirzepatide and looking at the broader cost and practicalities of treatment, the Mounjaro cost guide covers what private treatment typically involves. And if you have questions about how Mounjaro interacts with other aspects of your health, such as HRT or other conditions, those pages have detailed, prescriber-reviewed information.
Occasional, mild constipation in the early weeks of tirzepatide is common enough that a short course of an osmotic laxative is a reasonable first step, provided you have read the Laxido instructions and have no contraindications to it. Self-management is not appropriate if any of the following apply.
Constipation is accompanied by significant abdominal pain or bloating. You have not opened your bowels for several days despite trying a laxative. You notice blood in your stool. You are already taking multiple medicines whose absorption might be affected by altered gut motility. You have a pre-existing bowel condition. In those situations, your prescriber or a GP can assess whether the constipation is being driven by tirzepatide, by diet, by dehydration, or by something unrelated that needs its own investigation.
At nume, every prescription is reviewed by a GPhC-registered Independent Prescriber before it is issued, and aftercare is available seven days a week, so you have a clinical contact point if something like this comes up between doses. If you have broader questions about how tirzepatide works in the body, the tirzepatide overview and the Mounjaro information page cover the mechanism and licensed use in detail. Some people also ask about sexual health while on treatment, including whether Mounjaro can affect erectile dysfunction and how tirzepatide may influence libido, and both of those topics are covered in dedicated, prescriber-reviewed pages. You can also browse the FAQs or get in touch directly.
If you are not yet on treatment and are considering whether Mounjaro is right for you, the starting point is a clinical assessment. Check your eligibility through a free consultation with our prescribers.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.